StreetInsider.com News Articles

Altrova Health to Host Investor Q&A Session on Tuesday, October 20 at 10:00 A.M. ET

Tue, 20 Oct 2026 07:07:00 -0400

Toronto, Ontario--(Newsfile Corp. - October 20, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") today reminds shareholders and investors that it will host a live question-and-answer (Q&A) session on Tuesday, October 20, 2026 at 10:00 a.m. ET.

Further to the Company's news release dated October 19, 2026, announcing the first U.S. sale of 2,000 units of its O-Spray™ product, management will discuss the announcement and respond to general inquiries from shareholders and investors.

How to Join

Participants can join the session by clicking here.

Shareholders and investors are encouraged to join a few minutes early.

Altrova Health to Host Investor Q&A Session on Tuesday, October 20 at 10:00 A.M. ET

Tue, 20 Oct 2026 07:07:00 -0400

How to Join

Participants can join the session by clicking here.

Shareholders and investors are encouraged to join a few minutes early.

Altrova Health to Host Investor Q&A Session on Tuesday, October 20 at 10:00 A.M. ET

Tue, 20 Oct 2026 07:07:00 -0400

How to Join

Participants can join the session by clicking here.

Shareholders and investors are encouraged to join a few minutes early.

Altrova Health to Host Investor Q&A Session on Tuesday, October 20 at 10:00 A.M. ET

Tue, 20 Oct 2026 07:07:00 -0400

How to Join

Participants can join the session by clicking here.

Shareholders and investors are encouraged to join a few minutes early.

Altrova Health Announces First U.S. Sale of 2,000 O-Spray Units

Mon, 19 Oct 2026 14:21:00 -0400

Toronto, Ontario--(Newsfile Corp. - October 19, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") today announced the sale of 2,000 units of its O-Spray™ product pursuant to a sales agreement dated October 17, 2026, to a distributor of peptide products with a large network of healthcare practitioners and retail channels (the "Purchaser"). The sale marks the Company's entry into the United States market.

O-Spray is a needle-free sublingual oral spray dosage format that uses an airless metered-dose pump to deliver a precise, consistent dose with each actuation. It is designed as an alternative

Altrova Health Announces First U.S. Sale of 2,000 O-Spray Units

Mon, 19 Oct 2026 14:21:00 -0400

O-Spray is a needle-free sublingual oral spray dosage format that uses an airless metered-dose pump to deliver a precise, consistent dose with each actuation. It is designed as an alternative

Altrova Health Announces First U.S. Sale of 2,000 O-Spray Units

Mon, 19 Oct 2026 14:21:00 -0400

O-Spray is a needle-free sublingual oral spray dosage format that uses an airless metered-dose pump to deliver a precise, consistent dose with each actuation. It is designed as an alternative

Altrova Health Announces First U.S. Sale of 2,000 O-Spray Units

Mon, 19 Oct 2026 14:21:00 -0400

O-Spray is a needle-free sublingual oral spray dosage format that uses an airless metered-dose pump to deliver a precise, consistent dose with each actuation. It is designed as an alternative

Altrova Health Announces Closing of Financing

Tue, 13 Oct 2026 07:07:00 -0400

Toronto, Ontario--(Newsfile Corp. - October 13, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") is pleased to announce that, further to its news releases dated September 8, 2026, it has closed its non-brokered private placement (the "Offering") for total gross proceeds of C$669,840. Gross proceeds were raised through the issuance of 13,396,800 units (the "Units") at a price of $0.05 per Unit.

Each Unit consists of one common share of the Company (each, a "Common Share") and one warrant. Each whole warrant (each, a "Warrant") entitles the holder to purchase one additional Common

Altrova Health Announces Closing of Financing

Tue, 13 Oct 2026 07:07:00 -0400

Each Unit consists of one common share of the Company (each, a "Common Share") and one warrant. Each whole warrant (each, a "Warrant") entitles the holder to purchase one additional Common

Altrova Health Announces Closing of Financing

Tue, 13 Oct 2026 07:07:00 -0400

Each Unit consists of one common share of the Company (each, a "Common Share") and one warrant. Each whole warrant (each, a "Warrant") entitles the holder to purchase one additional Common

Altrova Health Announces Closing of Financing

Tue, 13 Oct 2026 07:07:00 -0400

Each Unit consists of one common share of the Company (each, a "Common Share") and one warrant. Each whole warrant (each, a "Warrant") entitles the holder to purchase one additional Common

Altrova Health Closes Debt Settlement

Tue, 29 Sep 2026 17:02:00 -0400

Toronto, Ontario--(Newsfile Corp. - September 29, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") is pleased to announce that it has closed a debt settlement involving the issuance of common shares in settlement of C$215,000 of bona fide indebtedness (the "Debt Settlement"). All dollar amounts in this news release are expressed in Canadian dollars unless otherwise indicated.

The Debt Settlement did not result in any cash proceeds to the Company, but reduced the Company's outstanding liabilities and preserved cash for working capital purposes.

Pursuant to the Debt Settlement, the Company settled an aggregate of

Altrova Health Closes Debt Settlement

Tue, 29 Sep 2026 17:02:00 -0400

The Debt Settlement did not result in any cash proceeds to the Company, but reduced the Company's outstanding liabilities and preserved cash for working capital purposes.

Pursuant to the Debt Settlement, the Company settled an aggregate of

Altrova Health Closes Debt Settlement

Tue, 29 Sep 2026 17:02:00 -0400

The Debt Settlement did not result in any cash proceeds to the Company, but reduced the Company's outstanding liabilities and preserved cash for working capital purposes.

Pursuant to the Debt Settlement, the Company settled an aggregate of

Altrova Health Closes Debt Settlement

Tue, 29 Sep 2026 17:02:00 -0400

The Debt Settlement did not result in any cash proceeds to the Company, but reduced the Company's outstanding liabilities and preserved cash for working capital purposes.

Pursuant to the Debt Settlement, the Company settled an aggregate of

Altrova Health Announces Proposed Debt Settlement

Wed, 16 Sep 2026 07:07:00 -0400

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Toronto, Ontario--(Newsfile Corp. - September 16, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") announces that it proposes to enter into debt settlement agreements with three consultants to settle aggregate indebtedness of C$215,000 through the issuance of an aggregate of 3,583,333 common shares of the Company ("Common Shares") at a deemed price of $0.06 per share (the "Debt Settlement").

The Debt Settlement is intended to reduce the Company's outstanding liabilities and preserve cash for working capital

Altrova Health Announces Proposed Debt Settlement

Wed, 16 Sep 2026 07:07:00 -0400

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

The Debt Settlement is intended to reduce the Company's outstanding liabilities and preserve cash for working capital

Altrova Health Announces Proposed Debt Settlement

Wed, 16 Sep 2026 07:07:00 -0400

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

The Debt Settlement is intended to reduce the Company's outstanding liabilities and preserve cash for working capital

Altrova Health Announces Proposed Debt Settlement

Wed, 16 Sep 2026 07:07:00 -0400

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

The Debt Settlement is intended to reduce the Company's outstanding liabilities and preserve cash for working capital

Altrova Health Inc. to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

Mon, 14 Sep 2026 07:09:00 -0400

Toronto, Ontario--(Newsfile Corp. - September 14, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") is pleased to announce its participation in the upcoming 3^rd Annual ArcStone-Kingswood Growth Summit in Toronto, taking place on September 16, 2026, at the Sheraton Center Toronto Hotel. Geoff Benic, Chief Executive Officer of Altrova Health, will be presenting on the company's recent milestones and future growth strategy.

The ArcStone-Kingswood Growth Summit will be hosting growth issuers and a curated group of investors, family offices, institutional investors, capital market professionals and service providers for a full day of company

Altrova Health Inc. to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

Mon, 14 Sep 2026 07:09:00 -0400

Altrova Health Inc. to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

Mon, 14 Sep 2026 07:09:00 -0400

Altrova Health Inc. to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

Mon, 14 Sep 2026 07:09:00 -0400

Altrova Health signs U.S. distribution deal, plans $500K placement

Tue, 08 Sep 2026 07:09:20 -0400

Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) has entered into an exclusive distribution agreement with Reliability Funding LLC, appointing the U.S.-based firm as its exclusive sales agent and distributor across the United States for its detection, protection, and wellness product portfolio, according to a company statement.

The agreement covers Altrova Health's current and future product lines, with the exception of the NIRLAB SA NIRLIGHT drug analysis device. Reliability Funding will be responsible for sales, business development, customer onboarding, and account management across retail, online, commercial, healthcare, and government channels. Altrova Health retains ownership of its brands, intellectual property, and